A Randomized, Placebo-Controlled Trial Evaluating Effects of Lebrikizumab on Airway Eosinophilic Inflammation and Remodeling in Uncontrolled Asthma (CLAVIER).

Cary D. Austin, Melissa Gonzalez Edick, Ronald E. Ferrando, Margaret Solon, Miriam Baca, Kathryn Mesh, Peter Bradding, Gail M. Gauvreau, Kaharu Sumino, Mark Fitzgerald, Eliott Israel, Leif Bjermer, Arnaud Bourdin, Joseph R. Arron, David F. Choy, Julie K. Olsson, Francis D. Abreu, Monet D. Howard, Kit D. Wong, Fang D. Cai, Kun D. Peng, Wendy S. Putman, Cécile T. J. Holweg, John G. Matthews, Monica Kraft, Prescott G. Woodruff. A Randomized, Placebo-Controlled Trial Evaluating Effects of Lebrikizumab on Airway Eosinophilic Inflammation and Remodeling in Uncontrolled Asthma (CLAVIER). The FASEB Journal. 2020 Apr 17; 34(S1):1-1.

2020
https://researcherprofiles.org/profile/246283262

Cary D. Austin, Melissa Gonzalez Edick, Ronald E. Ferrando, Margaret Solon, Miriam Baca, Kathryn Mesh, Peter Bradding, Gail M. Gauvreau, Kaharu Sumino, Mark Fitzgerald, Eliott Israel, Leif Bjermer, Arnaud Bourdin, Joseph R. Arron, David F. Choy, Julie K. Olsson, Francis D. Abreu, Monet D. Howard, Kit D. Wong, Fang D. Cai, Kun D. Peng, Wendy S. Putman, Cécile T. J. Holweg, John G. Matthews, Monica Kraft, Prescott G. Woodruff